Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22723-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- ARK5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ARK5 antibody (Cat. #22723-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references High-throughput kinase inhibitor screening reveals roles for Aurora and Nuak kinases in neurite initiation and dendritic branching.
miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.
A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation.
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Blazejewski SM, Bennison SA, Liu X, Toyo-Oka K
Scientific reports 2021 Apr 14;11(1):8156
Scientific reports 2021 Apr 14;11(1):8156
miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
Wu J, Yang B, Zhang Y, Feng X, He B, Xie H, Zhou L, Wu J, Zheng S
International journal of biological sciences 2019;15(8):1591-1599
International journal of biological sciences 2019;15(8):1591-1599
MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.
Yu Y, Wang Y, Xiao X, Cheng W, Hu L, Yao W, Qian Z, Wu W
Biochemistry and cell biology = Biochimie et biologie cellulaire 2019 Oct;97(5):563-570
Biochemistry and cell biology = Biochimie et biologie cellulaire 2019 Oct;97(5):563-570
A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation.
Esteve-Puig R, Gil R, González-Sánchez E, Bech-Serra JJ, Grueso J, Hernández-Losa J, Moliné T, Canals F, Ferrer B, Cortés J, Bastian B, Ramón Y Cajal S, Martín-Caballero J, Flores JM, Vivancos A, García-Patos V, Recio JÁ
PLoS genetics 2014 Oct;10(10):e1004721
PLoS genetics 2014 Oct;10(10):e1004721
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Cui J, Yu Y, Lu GF, Liu C, Liu X, Xu YX, Zheng PY
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Jun;34(3):1913-8
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Jun;34(3):1913-8
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse brain tissue were subjected to SDS PAGE followed by western blot with 22723-1-AP( NUAK1 Antibody) at dilution of 1:600
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ARK5 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human ARK5. This antibody recognizes human, mouse antigen. The ARK5 antibody has been validated for the following applications: ELISA, WB, IHC analysis.